Stories of DiscoveryImpact & Innovation
Explore the research, people, and breakthroughs shaping precision medicine and human health at Texas A&M University.
Featured Stories
IBT Study Explores Exosomal LINE-1 as a Liquid Biopsy Biomarker in Lung Cancer
A 2025 MedComm study from the Ramos laboratory at IBT, led by visiting scholar Dr. Abeer A.I. Hassanin, reported that exosomal LINE-1 mRNA profiles distinguished lung cancer from controls and reflected clinical features including stage, metastasis, and smoking history.
Dr. Yubin Zhou Receives NIGMS R35 Award for Calcium Signaling Research
Dr. Yubin Zhou has received an NIGMS R35 award to study how cells control calcium signals at membrane contact sites—basic biology that underpins growth, stress response, and communication inside living cells.
Dr. Thomas Kent Named to Super Doctors Legacy Hall of Fame
Dr. Thomas A. Kent, Welch Chair professor at IBT, has been named to the 2026 Texas Super Doctors list and reports Legacy Hall of Fame status for 15 consecutive years—clinical recognition for a physician-scientist rooted in research.
Texas A&M Health and Wave Neuroscience Announce FDA Clearance of MeRT for PTSD
In partnership with Wave Neuroscience, IBT investigators led a multisite clinical trial supporting FDA clearance of MeRT, the first personalized, biomarker-guided neuromodulation system cleared for post-traumatic stress disorder.
Dr. Yubin Zhou's Caffeine-Guided Gene Research Featured on Heliox Podcast
Dr. Yubin Zhou, director of the Center for Translational Cancer Research at IBT, discussed IBT-developed caffeine-activated genetic tools on the Heliox podcast, following coverage in the Journal of the American Chemical Society and Vital Record.
IBT Researchers Featured in Landmark Drug Discovery Today Article on Statewide Innovation Model
Led by Dr. Suzanne Tomlinson-Mathis, PhD, MBA, director of innovation and entrepreneurship at IBT, a Drug Discovery Today feature highlights Dr. Peter Davies, Dr. Clifford Stephan, and Dr. Margie Moczygemba and the IDDD Core Network, which has supported more than 750 projects and helped launch more than 60 startups.
Impact at IBT
Advancing bioscience discovery and training the next generation of scientific leaders in the Texas Medical Center.
Browse by Category
Stay connected with IBT stories
Questions about research highlights or media opportunities? Our communications team is here to help.
Contact IBT Communications